Variable | Clinical information | Personal interaction | Recommendation | |||
---|---|---|---|---|---|---|
 | B a | 95 % CI | B a | 95 % CI | B a | 95 % CI |
Age, years | Â | Â | Â | Â | Â | Â |
 18–44 | −0.18b | −0.47, 0.11 | −0.19b | −0.48, 0.10 | −0.17b | −0.42, 0.08 |
 45–65 (reference) |  |  |  |  |  |  |
  > 65 | 0.19b | −0.09, 0.46 | 0.24c | −0.06, 0.53 | 0.23d | −0.07, 0.53 |
Sex | Â | Â | Â | Â | Â | Â |
 Female | −0.02 | −0.10, 0.08 | 0.04 | −0.06, 0.15 | 0.12 | 0.02, 0.21 |
 Male (reference) |  |  |  |  |  |  |
Education | Â | Â | Â | Â | Â | Â |
 University education | −0.24c | −0.43, −0.03 | 0.01 | −0.15, 0.20 | −0.22d | −0.41, −0.03 |
 Secondary/PT (reference) |  |  |  |  |  |  |
 Primary education | 0.16 | −0.04, 0.36 | 0.02 | −0.16, 0.21 | 0.10 | −0.09, 0.30 |
 No schooling | 0.18b | −0.03, 0.39 | 0.11 | −0.08, 0.31 | 0.17b | −0.02, 0.33 |
Income, Euros | Â | Â | Â | Â | Â | Â |
  > 1800 | −0.08 | −0.14, 0.03 | −0.06 | −0.15, 0.03 | −0.10 | −0.2, 0.01 |
 1201–1800 (reference) |  |  |  |  |  |  |
 901–1200 | 0.01 | −0.13, 0.14 | 0.10 | −0.05, 0.16 | −0.11 | −0.25, 0.12 |
  ≤ 900 | 0.09 | −0.04, 0.22 | 0.10 | −0.02, 0.13 | 0.03 | −0.09, 0.16 |
QDU visits | Â | Â | Â | Â | Â | Â |
  ≤ 2 (reference) |  |  |  |  |  |  |
 3 | 0.01 | −0.34, 0.35 | 0.02 | −0.27, 0.33 | −0.01 | −0.35, 0.32 |
  ≥ 4 | −0.02 | −0.37, 0.33 | 0.02 | −0.32, 0.40 | −0.17b | −0.52, 0.16 |
Diagnosis | Â | Â | Â | Â | Â | Â |
 Malignancy | −0.20 b | −0.59, 0.21 | −0.09 | −0.48, 0.30 | −0.18b | −0.57, 0.21 |
 Benign diseases (reference) |  |  |  |  |  |  |